News Articles

  • As medical professionals worldwide explored treatment options for COVID-19, a University of Iowa Health Care infectious disease research team participated in a clinical study on remdesivir—an intravenous antiviral drug that’s shown the potential to shorten recovery time and reduce deaths. Read more
  • University of Iowa Hospitals & Clinics, the patient care mission of University of Iowa Health Care, is the first in the state of Iowa to participate in an international clinical trial for a Remdesivir, believed to be the most promising drug available to treat COVID-19. Read more
  • University of Iowa researchers will help test one of two new investigational vaccines to prevent infection with the deadly H7N9 influenza virus. Read more